(1 - 12 von 21
)
Merck KGaA starts mid-stage multiple-sclerosis trial | Reuters
www.reuters.com
Merck KGaA has started a mid-stage trial to evaluate the safety and efficacy of atacicept in patients with relapsing multiple sclerosis, the German drugs and...
Patient engagement was a highlight of #DIA2017
medcitynews.com
— Anton Hoos, chief of medical for Amgen in Europe, agreed. Organizations across the board need to move together to involve patients in drug ... ›
Patients as Partners Europe Crunchbase
www.crunchbase.com
Speakers: Anton Hoos, Annick Anderson. Tuesday January 23, at 8:00 am (ends Wednesday January 24, at 5:00 pm). Read More ... › event
Merck Serono Announces Initiation Of Phase II Clinical Trial Of...
www.science20.com
"This trial with atacicept underlines Merck Serono's long-term commitment to patients with multiple sclerosis," said Dr. Anton Hoos, Head of ...
sortiert nach Relevanz / Datum